Multi-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain.
6 blocks of code here have a permanent identifier (oscr:b:…), listed with the matches below: citable for good, with a page of its own. Select a match and press Cite to copy it. What a block identifier is.
The 7 matches · 1 of them tie a paragraph to a whole file without given lines: a weak match, whose lines are not tinted
- [1] § Results › Specific 5mC methylation patterns present in the CSF cfDNA of brain metastasis ↔ CSF_cfDNA_5mC_5hmC_analysis.R, lines 54 to 104 · score 0.75 · IL1R2, RAD54B, CCNH, CD74, ZKSCAN1, MID1 · block
oscr:b:VKP2Q81X25AKX-X· Report a mismatch - [2] § Results › Comparing the methylation of brain metastasis CSF cfDNA to NSCLC primary tumor DNA ↔ CSF_cfDNA_5mC_5hmC_analysis.R, lines 54 to 104 · score 0.68 · ATAD3A, COL6A6, RAD54B, MIF, MMP13, overlapped · block
oscr:b:VKP2Q81X25AKX-X· Report a mismatch - [3] § Results › Decreased intragenic hydroxymethylation in the CSF cfDNA of brain metastasis ↔ CSF_cfDNA_5mC_5hmC_analysis.R, lines 106 to 146 · score 0.68 · IL21R, ADCY9, HDAC9, KCNQ1, MTDH, PBX1 · block
oscr:b:9J24ZEXNRPRFS-7· Report a mismatch - [4] § Results › Decreased intragenic hydroxymethylation in the CSF cfDNA of brain metastasis ↔ cfDNA_enrichr_analysis.R, lines 52 to 91 · score 0.57 · PPI Hub Proteins, Transcription Factor, hmCG, Enrichr, bar · block
oscr:b:FTZQY63DY09AF-D· Report a mismatch - [5] § Materials and methods › Methylation and hydroxymethylation analysis of CSF cfDNA ↔ CSF_cfDNA_5mC_5hmC_analysis.R, lines 1 to 52 · score 0.56 · GENCODE v38, intersecting, FDR, hydroxymethylation, protein, promoter · block
oscr:b:W4AFK99DDZW28-U· Report a mismatch - [6] § Results › Features of CSF cfDNA level among patients with brain metastasis ↔ CSF_cfDNA_sequencing_coverage.R, the whole file · a weak match · score 0.54 · sequencing coverage, CSF volumes, CSF samples, DNA, cancer · block
oscr:b:MMK8VH8JPA6BN-T· Report a mismatch - [7] § Results › CSF cfDNA profiles reveal longitudinal changes from clinical events ↔ CSF_plasma_cfDNA_size_comparision.R, lines 189 to 229 · score 0.54 · dt_ratio, md_ratio, mt_ratio, nucleosome ratios, dinucleosome, trinucleosome · block
oscr:b:27WPQYTHS9BP8-F· Report a mismatch
Paper
Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC
The paper is loaded when this pane is shown.
The authors' code
R · 253 lines · 9.5 KB · MIT · 4 matches
- # CSF_cfDNA_5mC_5hmC_analysis.R
- # this file is meant to be used inside Rstudio
- # this script takes in promoter methylation (5mC) & intragenic hydroxymethylation (5hmC) % per CpG site with fdr-corrected q values, groups by gene level
- # and plots the promoter 5mC% or intragenic 5hmC% per gene (volcano plot) or per sample (point plot) for both cancer and control
- # this file was generated using bedtools intersect with GENCODE v38:
- # bedtools intersect -a gencode.v38.genes.sorted.bed -b P1.5mC.sorted.bedgraph -wa -wb -sorted | awk '{print($0 '\tP1')}' > P1.5mC.sorted.genes.intersect.bed
- # P1.5mC.sorted.bedgraph is a bedgraph of the modified_bases.5mC.bed from dorado, filtered on column 5 > 0, and extracting only the chrom, start, end, and percent methylation columns
- # multiple intersected bed files can be joined using cat, and fed into this script.
- library(data.table)
- library(dplyr)
- library(ggplot2)
- library(ggrepl)
- library(tidyverse)
- # plot differential prmoter 5mCG% and intragenic 5hmCG% between cancer and control CSF of all genes in volcano plot
- # read in merged bed files
- # promoter 5mCG
- hyper_pro_5mc <- fread("/mnt/ix1/Projects/M085_221117_CSF_cfDNA_methylation/03_statistical_test/04_volcano_plot/02_samples/gene_summary/hyper.2kbpromoter_summary_5mCG.txt")
- hypo_pro_5mc <- fread("/mnt/ix1/Projects/M085_221117_CSF_cfDNA_methylation/03_statistical_test/04_volcano_plot/02_samples/gene_summary/hypo.2kbpromoter_summary_5mCG.txt")
- # intragenic 5hmCG
- hyper_5hmc <- fread("/mnt/ix1/Projects/M085_221117_CSF_cfDNA_methylation/03_statistical_test/04_volcano_plot/02_samples/gene_summary/hyper.genebody_summary_5hmCG.txt")
- hypo_5hmc <- fread("/mnt/ix1/Projects/M085_221117_CSF_cfDNA_methylation/03_statistical_test/04_volcano_plot/02_samples/gene_summary/hypo.genebody_summary_5hmCG.txt")
- # gene analysis
- # diff_methyl = 5mCG% (cancer ) - 5mCG% (control) per gene
- # promoter 5mCG
- # use gencodev38 gene names to filter protein_coding genes
- gencode <- fread("/mnt/ix1/Projects/M086_221117_TGP_cfDNA_methylation/annotation/gencode.v38.genes_summary.txt")
- gencode_proteincoding <- gencode %>% filter(V5=='protein_coding')
- protein_coding_genes <- unique(gencode_proteincoding$V6)
- hyper_pro_5mc_mean <- hyper_pro_5mc %>%
- select(c('V5', 'V6', 'V10', 'V11')) %>%
- rename(gene = V5, gene_id = V6,
- diff_methyl = V10, qval = V11) %>%
- filter(gene %in% protein_coding_genes)
- hypo_pro_5mc_mean <- hypo_pro_5mc %>%
- select(c('V5', 'V6', 'V10', 'V11')) %>%
- rename(gene = V5, gene_id = V6,
- diff_methyl = V10, qval = V11) %>%
- filter(gene %in% protein_coding_genes)
- df_pro_5mc <- rbind(hyper_pro_5mc_mean, hypo_pro_5mc_mean)
- # add legend to the plot
- df_pro_5mc <- df_pro_5mc %>%
- mutate(group = case_when(
- qval < 0.01 & diff_methyl > 0 ~ "hypermethylated in cancer",
- qval < 0.01 & diff_methyl < 0 ~ "hypomethylated in cancer",
- TRUE ~ "Background"))
- # add reported marker labels on the plot
- df_marker_pro_5mc <- df_pro_5mc %>%
- filter(gene %in% c('ATAD3A','CCNH','CD74','DYRK2','IL1R2',
- 'LIPH','MID1','MIF','MMP13','RAD54B',
- 'SETDB1','ZKSCAN1','COL6A6',
- 'EPB41L1','IL6R','PER3')) %>%
- filter(qval<0.01) %>% group_by(gene, diff_methyl,qval) %>%
- summarize(n = n())
- # plot the volcano plot
- p1_2 <- ggplot(data=df_pro_5mc, aes(x=diff_methyl, y=-log10(1e-5+qval))) +
- geom_point(aes(color=group),size=6, alpha=0.6) +
- scale_color_manual(name ='type',
- values = c("hypermethylated in cancer" = "#CC79A7",
- "hypomethylated in cancer" = "#009E73")) +
- geom_text_repel(data = df_marker_pro_5mc,
- aes(x= diff_methyl, y=-log10(1e-5+qval), label = gene),
- min.segment.length = 0,
- max.overlaps=Inf,
- size = 8 ) +
- labs(x='CpG promoter 5mCG difference per gene (%)') +
- theme_classic(30) +
- theme(axis.text = element_text(face = 'bold'),
- axis.title = element_text(face = 'bold'))
- p1_2
- # intragenic 5hmCG
- hyper_5hmc_mean <- hyper_5hmc %>%
- select(c('V5', 'V6', 'V10', 'V11')) %>%
- rename(gene_type = V5, gene = V6,
- diff_methyl = V10, qval = V11) %>%
- filter(gene_type == 'protein_coding')
- hypo_5hmc_mean <- hypo_5hmc %>%
- select(c('V5', 'V6', 'V10', 'V11')) %>%
- rename(gene_type = V5, gene = V6,
- diff_methyl = V10, qval = V11) %>%
- filter(gene_type == 'protein_coding')
- df_5hmc <- rbind(hyper_5hmc_mean, hypo_5hmc_mean)
- # add legend to the plot
- df_5hmc <- df_5hmc %>%
- mutate(group = case_when(
- qval < 0.01 & diff_methyl > 0 ~ "hyper-hydroxymethylated in cancer",
- qval < 0.01 & diff_methyl < 0 ~ "hypo-hydroxymethylated in cancer",
- TRUE ~ "Background"))
- # add reported marker labels on the plot
- df_marker_5hmc <- df_5hmc %>%
- filter(gene %in% c('ADCY9','HDAC9','IL21R','KCNQ1',
- 'MTDH','PBX1','SASH1','TPST1','TWIST2')) %>%
- filter(qval<0.01) %>% group_by(gene, diff_methyl,qval) %>%
- summarize(n = n())
- # plot the volcano plot
- p1_2 <- ggplot(data=df_5hmc, aes(x=diff_methyl, y=-log10(1e-6 + qval))) +
- geom_point(aes(color=group),size=6, alpha=0.6) +
- scale_color_manual(name ='type', values = c("hyper-hydroxymethylated in cancer" = "#CC79A7",
- "hypo-hydroxymethylated in cancer" = "#009E73")) +
- geom_text_repel(data = df_marker_5hmc,
- aes(x = diff_methyl, y = -log10(1e-6 + qval), label = gene),
- min.segment.length = 0,
- max.overlaps = Inf,
- size = 8) +
- labs(x='CpG intragenic 5hmCG difference per gene (%)') +
- theme_classic(30) +
- theme(axis.text = element_text(face = 'bold'),
- axis.title = element_text(face = 'bold'))
- p1_2
- ggsave("5mCG_promoter_volcano.png", plot = p1_1, dpi = 300, units = "in", height = 12, width = 20)
- ggsave("5hmCG_intragenic_volcano.png", plot = p1_2, dpi = 300, units = "in", height = 12, width = 20)
- # plot differential prmoter 5mCG% and intragenic 5hmCG% of marker genes per sample
- # these marker genes were defined as sig genes (q<0.01) between cancer vs. control CSF samples, and reported in the literature as biomarkers for NSCLC
- # e.g. a sig gene that was hypomethylated in our data and reported as an upregulated marker/overexpressed in NSCLC patients
- # promoter 5mCG
- p2_1 <- ggplot(marker_5mc_pro, aes(x= gene, y= mean_methyl, color = type)) +
- geom_jitter(size=6, alpha=0.6, width = 0.3, height = 2) +
- #scale_y_continuous(limits = c(0,100), breaks = c(0,50,100)) +
- geom_vline(xintercept = c(1.5,2.5,3.5,4.5,5.5,6.5,7.5,8.5,9.5,
- 10.5,11.5,12.5,13.5,14.5,15.5),
- linetype="dotted",size=0.5) +
- labs(x = "Gene" ,y ="CpG promoter 5mCG
- per sample (%)") +
- theme_classic(25) +
- theme(axis.text = element_text(face = "bold"),
- axis.title = element_text(face = "bold"),
- axis.text.x = element_text(angle = -45, hjust = 0.05))
- p2_1
- # intragenic 5hmCG
- p2_2 <- ggplot(marker_5hmc, aes(x= gene, y= mean_methyl, color = type)) +
- geom_jitter(size=6, alpha=0.6, width = 0.3, height = 2) +
- #scale_y_continuous(limits = c(0,100), breaks = c(0,50,100)) +
- geom_vline(xintercept = c(1.5,2.5,3.5,4.5,5.5,6.5,7.5,8.5),
- linetype="dotted",size=0.5) +
- labs(x = "Gene" ,y ="CpG intragenic 5hmCG
- per sample (%)") +
- theme_classic(30) +
- theme(axis.text = element_text(face = "bold"),
- axis.title = element_text(face = "bold"),
- axis.text.x = element_text(angle = -45, hjust = 0.05))
- p2_2
- ggsave("5mCG_promoter_marker_plot.png", plot = p2_1, dpi = 300, units = "in", height = 8, width = 20)
- ggsave("5hmCG_intragenic_marker_plot.png", plot = p2_2, dpi = 300, units = "in", height = 10, width = 16)
- # plot average genome-wide 5hmCG% between cancer and control CSF samples
- # read in the merged bedmethyl files for 5hmCG
- # these are bedgraphs containing 5hmC% before intersecting with GENCODE
- cpg_5hmc <- fread("/mnt/ix1/Projects/M085_221117_CSF_cfDNA_methylation/00_sample/mp0007_sample_summary_sup_methyl/sorted_bedgraph/5hmCG/merged.genomewide.5hmCG.txt")
- cpg_5hmc <- cpg_5hmc %>% mutate(type = ifelse(grepl('control',V5),'Healthy','Cancer'))
- # calculate average genome-wide 5hmCG%
- avg_5hmc <- cpg_5hmc %>% group_by(V5,type) %>%
- summarise(mean_5hmCG = mean(V4)) %>%
- mutate(m = signif(mean_5hmCG,2))
- # plot
- p3_1 <- ggplot(avg_5hmc, aes(x= type, y= mean_5hmCG, fill = type)) +
- geom_boxplot(width=0.7) +
- labs(x = NULL, y ="Average genome-wide
- 5hmCG (%)") +
- #scale_y_continuous(limits = c(0.8,9), breaks = c(1,3,5,7,9)) +
- theme_classic(25) +
- theme(axis.text = element_text(face = "bold"),
- axis.title = element_text(face = "bold"))
- p3_1
- p3_2 <- ggplot(avg_5hmc, aes(x= m, fill = type)) +
- geom_bar(width=0.1, color ='black') +
- labs(x = "Average genome-wide 5hmCG (%)", y ="Number of samples", fill = "Type") +
- #scale_x_continuous(limits = c(54,72), breaks = c(54,60,66,72)) +
- #scale_y_continuous(limits = c(0,2), breaks = c(0,1,2)) +
- facet_wrap(~ type, ncol = 1) +
- theme_classic(40) +
- theme(strip.text = element_text(size = 40),
- axis.text = element_text(face = "bold"),
- axis.title = element_text(face = "bold"),
- panel.margin = unit(0, "lines"))
- p3_2
- # caculate p value for the box plot
- p_5hmc <- avg_5hmc %>% summarise(p=t.test(mean_5hmCG[type=='Healthy'], mean_5hmCG[type=='Cancer'])$p.value)
- ggsave("genomewide_avg_5hmCG_boxplot.png", plot = p3_1, dpi = 300, units = "in", height = 6, width = 8)
- ggsave('genomewide_avg_5hmCG_barplot.png', plot = p3_2, dpi = 300, units = 'in', height = 10, width = 20)
CSF_cfDNA_5mC_5hmC_analysis.R at commit e393d61, under MIT · at the source
Overview
- Division of Oncology, Department of Medicine, Stanford University, School of Medicine, Stanford, CA 94305, United States
- Department of Neurosurgery, Stanford University, Stanford, CA 94305, United States
- Department of Electrical Engineering, Stanford University, Stanford, CA 94305, United States
Abstract
Cerebrospinal fluid (CSF) is a liquid biological medium immersing the brain and spinal canal. For patients with metastatic cancer from the lung, tumor cells release their cell-free DNA (cfDNA) into the CSF. We applied a nanopore single-molecule sequencing approach to analyze the fragmentation, methylation, and hydroxymethylation patterns present in CSF-derived cell-free DNA from patients with metastatic lung cancer to the brain. We compared the cancer cfDNA finding to non-cancer healthy controls and their CSF cell-free DNA. Among cancer patients, we observed enriched mono-nucleosome levels and significantly higher mono-/
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Repositories
Its files are read in the Code ↔ Paper reader above, with 7 matches between paragraphs and lines of code.
Tianqi-Kiki/nanopore_CSF_cfDNA
e393d614799ee1a94bcbb550de6d920429c50c69, 24 July 2025Availability: 1 check, the latest on 27 September 2026: the link answers
- 27 September 2026: the link answers
7 files
- CSF_cfDNA_5mC_5hmC_analy
sis.R , R, 253 lines, 4 matches - CSF_cfDNA_sequencing_cov
erage.R , R, 92 lines, 1 match - CSF_cfDNA_size_analysis.
R , R, 150 lines - CSF_plasma_cfDNA_size_co
mparision.R , R, 337 lines, 1 match - cfDNA_enrichr_analysis.R
, R, 209 lines, 1 match - LICENSE, License, 21 lines
- README.md, Text, 46 lines
Zenodo 20173042
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
- 27 September 2026: the link answers (HTTP 200)
7 files
- CSF_cfDNA_5mC_5hmC_analy
sis.R , R, 253 lines - CSF_cfDNA_sequencing_cov
erage.R , R, 92 lines - CSF_cfDNA_size_analysis.
R , R, 150 lines - CSF_plasma_cfDNA_size_co
mparision.R , R, 337 lines - cfDNA_enrichr_analysis.R
, R, 209 lines - LICENSE, License, 21 lines
- README.md, Text, 46 lines
The paper's code and data availability statement is in the Data section.
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 2 repositories of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 10 scripts, each with its path and the digest of its content;
- 7 matches between paragraphs of the paper and lines of the code (method lexical-v1);
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
No dataset and no data link were found in the paper.
Data availability
Sequence-aligned BAM files and associated methylation calls are deposited in NCBI’s dbGAP under accession phs003794.v1.p1 (https://
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 15 MeSH terms, 2 funders, 85 references.
Cite
This paper
Chen, T., Bai, X., Burnside, G., Trinh, T. T. H., Gephart, M. H., Ji, H. P., & Lau, B. T. (2026). Multi-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain. NAR cancer, 8(3), zcag021. https://
BibTeX
@article{chen2026multi,
author = {Chen, Tianqi and Bai, Xiangqi and Burnside, Georgiana and Trinh, Thy Trang Hoang and Gephart, Melanie Hayden and Ji, Hanlee P and Lau, Billy T},
title = {{Multi-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain}},
journal = {NAR cancer},
year = {2026},
month = aug,
volume = {8},
number = {3},
pages = {zcag021},
publisher = {Oxford University Press},
issn = {2632-8674},
doi = {10.1093/
url = {https://
pmid = {42676708},
pmcid = {PMC13527165}
}
RIS
TY - JOUR
AU - Chen, Tianqi
AU - Bai, Xiangqi
AU - Burnside, Georgiana
AU - Trinh, Thy Trang Hoang
AU - Gephart, Melanie Hayden
AU - Ji, Hanlee P
AU - Lau, Billy T
TI - Multi-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain
T2 - NAR cancer
J2 - NAR Cancer
PY - 2026
DA - 2026/
VL - 8
IS - 3
SP - zcag021
SN - 2632-8674
PB - Oxford University Press
DO - 10.1093/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1093/
"type": "article-journal",
"title": "Multi-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain",
"container-title": "NAR cancer",
"author": [
{
"family": "Chen",
"given": "Tianqi"
},
{
"family": "Bai",
"given": "Xiangqi"
},
{
"family": "Burnside",
"given": "Georgiana"
},
{
"family": "Trinh",
"given": "Thy Trang Hoang"
},
{
"family": "Gephart",
"given": "Melanie Hayden"
},
{
"family": "Ji",
"given": "Hanlee P"
},
{
"family": "Lau",
"given": "Billy T"
}
],
"container-title-short":
"volume": "8",
"issue": "3",
"page": "zcag021",
"DOI": "10.1093/
"PMID": "42676708",
"PMCID": "PMC13527165",
"ISSN": "2632-8674",
"publisher": "Oxford University Press",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
31
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13059-025-03808-y [code]
- A ternary-code DNA methylome atlas of mouse tissues.Journal: Genome biologyIn common: data.table, ggplot2, tidyverse, genetics / omics, 3 references
- [2] doi:10.1158/2159-8290.cd-25-0074 [code]
- Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes.Journal: Cancer discoveryIn common: data.table, ggplot2, tidyverse, genetics / omics, other condition, 2 references
- [3] doi:10.1038/s41467-023-36707-6 [code]
- Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas.Journal: Nature communicationsIn common: data.table, ggplot2, tidyverse, genetics / omics, other condition, 2 references
- [4] doi:10.1073/pnas.2322834121
- Resolving the 22q11.2 deletion using CTLR-Seq reveals chromosomal rearrangement mechanisms and individual variance in breakpoints.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: genetics / omics, author Hanlee P Ji
- [5] doi:10.3389/fneur.2026.1822479 [code]
- Circulating neuron-derived cfDNA for blood-based detection of Alzheimer's and other neurodegenerative conditions.Journal: Frontiers in neurologyIn common: ggplot2, tidyverse, genetics / omics, other condition, 2 references
- [6] doi:10.1016/j.ccell.2023.07.010 [code]
- Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits.Journal: Cancer cellIn common: data.table, ggplot2, tidyverse, genetics / omics, other condition, 2 references
- [7] doi:10.1038/s43018-026-01115-4 [code]
- M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumors.Journal: Nature cancerIn common: genetics / omics, other condition, 3 references
- [8] doi:10.1016/j.xcrm.2026.102651 [code]
- Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease.Journal: Cell reports. MedicineIn common: data.table, ggplot2, tidyverse, genetics / omics, other condition, 1 reference
- [9] doi:10.1038/s41467-024-50471-1 [code]
- Tumor detection by analysis of both symmetric- and hemi-methylation of plasma cell-free DNA.Journal: Nature communicationsIn common: data.table, ggplot2, tidyverse, genetics / omics, other condition, 1 reference
- [10] doi:10.3390/ijms26094198 [code]
- Evaluation of Illumina and Oxford Nanopore Sequencing for the Study of DNA Methylation in Alzheimer's Disease and Frontotemporal Dementia.Journal: International journal of molecular sciencesIn common: genetics / omics, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 2 repositories of the authors' code, each at its verified commit and with its license, 10 scripts, and 7 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:0921c65bd0439468…
Add the badge to the code's README
If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.
Markdown
<!-- oscr-badge:start -->
[](https://openscicode.org/badge/doi/10.1093/narcan/zcag021)
<!-- oscr-badge:end -->reStructuredText
.. oscr-badge:start
.. image:: https://openscicode.org/badge/doi/10.1093/narcan/zcag021.svg
:target: https://openscicode.org/badge/doi/10.1093/narcan/zcag021
:alt: OSCR
.. oscr-badge:endHTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1093/narcan/zcag021"><img src="https://openscicode.org/badge/doi/10.1093/narcan/zcag021.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".
If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Report a mismatch between the code and the paper · Report a code error (signed in)
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Report a reproduction failure (signed in)
Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
